VSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients

Table 1 The expression level of VSTM1 in bone marrow cells from leukemia patients and healthy donors

Groups	MIC	Sample size	Mean ratio, *VSTM1* / *ABL*	P value ^a
HD		36	17.358 ± 17.904
Untreated AML		145	4.333 ± 7.895	<0.001
	M1	3	0.374 ± 0.619	n.a.
	M2	72	5.292 ± 10.171	<0.001
	M3	29	2.884 ± 3.960	<0.001
	M4	24	4.814 ± 5.293	0.001
	M5	14	3.052 ± 4.867	<0.001
	M6	3	1.417 ± 2.205	n.a.
Untreated ALL		40	0.381 ± 0.755	<0.001
Untreated CML		57	5.479 ± 8.266	<0.001
	CP	38	7.743 ± 9.312	0.001
	AP/BC	19	0.950 ± 1.367	<0.001

MIC morphological, immunological, and cytogenetic classifications, n.a. not available due to a small sample size.
^aThe P value was calculated using Wilcoxon signed ranks test as compared to the HD group.

ISSN: 1756-8722